Clinical experience with a new biocompatible phosphorylcholine-coated coronary stent.

Abstract

This initial clinical experience indicates that the implantation of stents coated with phosphorylcholine appears to be safe and efficacious in the treatment of complex coronary lesions and is associated with an extremely low target vessel revascularization rate.